Review
Off-label use of intravitreal bevacizumab for severe retinopathy of prematurity
Uso off-label de bevacizumab intravítreo en retinopatía del prematuro severa
Servicio de Oftalmolopediatría, Instituto Oftalmológico Argentino, IOFA, Buenos Aires, Argentina
Read
818
Timeswas read the article
202
Total PDF
616
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2023 3 | 1 | 1 | 2 |
| 2018 2 | 14 | 4 | 18 |
| 2018 1 | 3 | 7 | 10 |
| 2017 12 | 16 | 7 | 23 |
| 2017 11 | 9 | 6 | 15 |
| 2017 10 | 41 | 3 | 44 |
| 2017 9 | 15 | 10 | 25 |
| 2017 8 | 18 | 3 | 21 |
| 2017 7 | 28 | 7 | 35 |
| 2017 6 | 19 | 9 | 28 |
| 2017 5 | 12 | 10 | 22 |
| 2017 4 | 36 | 11 | 47 |
| 2017 3 | 32 | 35 | 67 |
| 2017 2 | 30 | 3 | 33 |
| 2017 1 | 29 | 4 | 33 |
| 2016 12 | 24 | 6 | 30 |
| 2016 11 | 40 | 5 | 45 |
| 2016 10 | 60 | 7 | 67 |
| 2016 9 | 26 | 7 | 33 |
| 2016 8 | 21 | 4 | 25 |
| 2016 7 | 19 | 2 | 21 |
| 2016 6 | 22 | 16 | 38 |
| 2016 5 | 26 | 11 | 37 |
| 2016 4 | 28 | 7 | 35 |
| 2016 3 | 27 | 8 | 35 |
| 2016 2 | 20 | 9 | 29 |
Show all
